Evidence map›Paper›PMID 40849900›Full record

ArticleVirulence2025

Virulence factors are preserved within carbapenem-resistant

Mor N Lurie-Weinberger, Adi Cohen, Hadas Kon, Ophir Kastel, Alona Keren-Paz, David Schwartz, Jonathan Lellouche, Amir Nutman, Sammy Frenk, Vered Schechner and 12 more

Abstract read
In one paragraph

Article in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. High-Resolution Genomic Surveillance of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Population-based Study of Carbapenem-resistantOpen forum infectious diseases · 2026
    Article
  5. Phage-antibiotic synergy attenuatesFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Mor N Lurie-WeinbergerNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.ORCID 0000-0002-2488-3720
Adi CohenNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Hadas KonNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Ophir KastelNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Alona Keren-PazNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
David SchwartzNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Jonathan LelloucheNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Amir NutmanNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Sammy FrenkNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Vered SchechnerNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Elizabeth TemkinNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Lena E FribergDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.
George L DaikosFirst Department of Medicine, Laikon General Hospital, Athens, Greece.
Anna SkiadaFirst Department of Medicine, Laikon General Hospital, Athens, Greece.
Emanuele Durante-MangoniDepartment of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli, Italy.
Dafna YahavFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Leonard LeiboviciFaculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Yaakov DicksteinNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
Yael Dishon BenattarInstitute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.
Mical PaulInstitute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel.
Yehuda CarmeliNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv, Israel.
AIDA Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsCarbapenemsVirulence FactorsAcinetobacter InfectionsEvolution, MolecularHumansPhylogenyVirulenceWhole Genome SequencingAnti-Bacterial AgentsCarbapenemsVirulence FactorsAcinetobacter baumanniiantibiotic resistancecarbapenem resistanceevolutionvirulence factors

Identifiers

PMID40849900
PMCPMC12377095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.